These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35601615)

  • 21. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease.
    Guridi J; Obeso JA; Rodriguez-Oroz MC; Lozano AA; Manrique M
    Neurosurgery; 2008 Feb; 62(2):311-23; discussion 323-5. PubMed ID: 18382309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circuit Mechanisms of L-DOPA-Induced Dyskinesia (LID).
    Yang K; Zhao X; Wang C; Zeng C; Luo Y; Sun T
    Front Neurosci; 2021; 15():614412. PubMed ID: 33776634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson's disease patients.
    Dias CMV; Leal DAB; Brys I
    Int J Neurosci; 2023 Dec; 133(12):1319-1325. PubMed ID: 35603453
    [No Abstract]   [Full Text] [Related]  

  • 24. Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation.
    Li MH; Mestre TA; Fox SH; Taati B
    J Neuroeng Rehabil; 2018 Nov; 15(1):97. PubMed ID: 30400914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the Side Onset of Parkinson's Disease Influence the Time to Develop Levodopa-Induced Dyskinesia?
    Chung SJ; Yoo HS; Lee HS; Lee PH; Sohn YH
    J Parkinsons Dis; 2019; 9(1):241-247. PubMed ID: 30741690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.
    Yoo HS; Choi YH; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2251-2260. PubMed ID: 31643140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
    Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
    Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia.
    Ueno T; Yamada J; Nishijima H; Arai A; Migita K; Baba M; Ueno S; Tomiyama M
    Neurobiol Dis; 2014 Apr; 64():142-9. PubMed ID: 24398173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GraphNet-based imaging biomarker model to explain levodopa-induced dyskinesia in Parkinson's disease.
    Kim M; Kim JS; Youn J; Park H; Cho JW
    Comput Methods Programs Biomed; 2020 Nov; 196():105713. PubMed ID: 32846317
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Sun HM; Wang LN; Ji M; Gan CT; Yuan YS; Cao XY; Zhang H; Zhang KZ
    Quant Imaging Med Surg; 2022 Jun; 12(6):3264-3275. PubMed ID: 35655818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of torsinA expression in the globus pallidus internus is associated with levodopa-induced dyskinesia in hemiparkinsonian rats.
    Yamada K; Goto S; Kaji R; Kuratsu J
    Neurosci Lett; 2006 Mar; 396(1):62-6. PubMed ID: 16325337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Levo-dopa induced Dyskinesias in Parkinson's Disease.
    Athulya RT; Jayakrishnan S; Iype T; Rajan R; Alapatt PJ
    Ann Indian Acad Neurol; 2020; 23(1):44-47. PubMed ID: 32055121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia.
    Jeong EH; Sunwoo MK; Song YS
    Front Neurol; 2018; 9():1133. PubMed ID: 30619078
    [No Abstract]   [Full Text] [Related]  

  • 34. Fyn knockdown prevents levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
    Bordone MP; Damianich A; Bernardi MA; Eidelman T; Sanz-Blasco S; Gershanik OS; Avale ME; Ferrario JE
    eNeuro; 2021 Jun; 8(4):. PubMed ID: 34099487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming.
    Nishijima H; Mori F; Arai A; Zhu G; Wakabayashi K; Okada M; Ueno S; Ichinohe N; Suzuki C; Kon T; Tomiyama M
    Neurobiol Dis; 2020 Sep; 143():104979. PubMed ID: 32590036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.
    Sellnow RC; Steece-Collier K; Altwal F; Sandoval IM; Kordower JH; Collier TJ; Sortwell CE; West AR; Manfredsson FP
    J Neurosci; 2020 Apr; 40(18):3675-3691. PubMed ID: 32238479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of levodopa effects by internal pallidal stimulation.
    Krack P; Pollak P; Limousin P; Hoffmann D; Benazzouz A; Benabid AL
    Mov Disord; 1998 Jul; 13(4):648-52. PubMed ID: 9686769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias.
    Jin X; Schwabe K; Krauss JK; Alam M
    Exp Brain Res; 2016 Apr; 234(4):1105-18. PubMed ID: 26724931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain-Region Specific Metabolic Abnormalities in Parkinson's Disease and Levodopa-Induced Dyskinesia.
    Yang C; Zhang T; Wang W; Xiang Y; Huang Q; Xie C; Zhao L; Zheng H; Yang Y; Gao H
    Front Aging Neurosci; 2020; 12():75. PubMed ID: 32256342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
    Calabresi P; Standaert DG
    Neurobiol Dis; 2019 Dec; 132():104579. PubMed ID: 31445160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.